Global Urinalysis Market will reach USD 1.88 billion by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Urinalysis Market will reach USD 1.88 billion by 2021, growing at a CAGR of 6.2% – Zion Market Research

Sarasota, FL, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Urinalysis Market (Consumables, Instruments) for Kidney Diseases, Hypertension, Urinary Tract Infection, Diabetes, Liver Diseases and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021” . According to the report, global demand for  urinalysis market  was valued at around USD 1.35 billion in 2015 and is expected to generate revenue of around USD 1.88 billion by end of 2021, growing at a CAGR of around 6.2% between 2016 and 2021. 

Urinalysis is the analysis of urine to diagnose various health disorders. It may be used to screen for and/or help diagnose conditions such as urinary tract infections, kidney disorders, liver problems, diabetes or other metabolic conditions. Urinalysis helps in detection of abnormalities which might require additional testing and follow-up investigation.

Browse 27 Market Tables and 22 Figures spread through 110 Pages and an in-depth TOC on “Urinalysis Market: Global Size, Shares, Trends, Segment & Forecast to 2021”

Request free Sample Report @ https://www.zionmarketresearch.com/sample/urinalysis-market

Global urinalysis market is primarily driven by growing incidences of target disease such as kidney disorders, liver problems, diabetes. Other major driving factors for the growth of urinalysis market are growing geriatric population coupled along with the introduction of technologically advanced diagnostics. However, strict government regulations implied on this industry and lack of healthcare infrastructure are major restraints that may curb the growth of the market. Nonetheless, the huge base of the target population and unmet clinical needs in under developed countries is likely to disclose the new avenues for urinalysis market in the near future.

The urinalysis market is segmented on the basis of different products including consumables, instruments. In 2015, consumables segment was the largest segment in urinalysis market and accounted for largest share of the total market. Reagents, dipstick, and disposables are the major consumables used in urinalysis. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period.

Browse the full " Urinalysis Market (Consumables, Instruments) for Kidney Diseases, Hypertension, Urinary Tract Infection, Diabetes, Liver Diseases and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 " report at  https://www.zionmarketresearch.com/report/urinalysis-market

Kidney diseases, hypertension, urinary tract infection, diabetes, liver diseases, and others are the key applications segment of the global urinalysis market. The urinary tract infections (UTI) application segment dominated the market in terms of revenue. Urinary tract infections (UTI) application segment hold more than 20% share of urinalysis market. Kidney diseases, hypertension, and diabetes are other major application segments of urinalysis market.

North America represents developed regional markets for urinalysis and expected to see the stable growth through the next few years. North America holds more than 40% share of global urinalysis market. Growing geriatric population coupled along with the occurrence of target disease such as diabetic retinopathy and chronic diseases are driving urinalysis industry in this region.  Moreover, advanced healthcare infrastructure and high disposable income in this region are expected further boost the demand for urinalysis market in North America.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/urinalysis-market

Europe is the second largest market for urinalysis.  The increase in number of elderly population in this region is expected to drive urinalysis market. Asia Pacific is another leading regional market and is expected to be the fastest regional segment for the urinalysis market within the forecast period. In Asia, China and India will continue to be the fastest growing markets in urinalysis market as a result of increasing health awareness and disposable income in this region.

As a result of increasing health awareness in Brazil, Latin America regional market is expected to grow at a noticeable growth rate in the global urinalysis market. The Middle East & Africa is expected to grow at a moderate growth rate during the forecast period.

Some of the key players in urinalysis market include Mindray, Roche Diagnostics, Siemens Healthcare, Sysmex, ARKRAY Inc., Alere Inc., ACON Laboratories, Inc., Bio-Rad, Labomed, Inc. Teco Diagnostics and Unit Medical., among others.

Ask for a customize report @ https://www.zionmarketresearch.com/custom/162

This report segments the global urinalysis market as follows:

Global Urinalysis Market: Product Segment Analysis

  • Consumables
  • Instruments

Global Urinalysis Market: Application Segment Analysis

  • Kidney Diseases
  • Hypertension
  • Urinary Tract Infection
  • Diabetes
  • Liver Diseases
  • Others

Related Reports:

 

 

 

 

 

Global Urinalysis Market: Regional Segment Analysis

  • North America
    • S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...sis-market

About Us:

Zion Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Market Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each Zion Market Research syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food and beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rosti Group Expands with Alvi Acquisition

Updated Category News Views 139

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 0

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 98

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 57

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 119

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Bybit Expands On-Chain Access: Japanese Equity Focus

Updated Category News Views 71

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 109

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Biond's BND-67 Trial: New Hope Against Tumors

Updated Category News Views 55

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Continue Reading
Foundayo Aims to Revolutionize Sleep Apnea Treatment

Updated Category News Views 81

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Continue Reading

Top 5 Most Recently Viewed Articles

Sulliden Mining Capital's Annual Meeting Results Unveiled

Updated Category News Views 159

Sulliden Mining Capital's Annual Meeting Results Unveiled On June 30, 2025, Sulliden Mining Capital Inc. (TSX: SMC) held its Annual and Special Meeting of Shareholders. This event followed the guidelines established by the Toronto Stock Exchange. During the meeting, shareholders engaged in an essential process—electing nominees presented in the management information...

Continue Reading
Ascential Medical's Dynamic Leadership Changes for Growth

Updated Category News Views 348

Leadership Changes at Ascential Medical & Life Sciences Ellen Scipta and Chris Cowen are stepping into pivotal roles as CFO and CCO at Ascential Medical & Life Sciences, while Todd Martensen transitions to the role of CSO. These changes reflect the company's commitment to innovation and strategic growth. Introducing Ellen Scipta: New Chief Financial Officer Ellen Scipta...

Continue Reading
Investors Target Xerox Holdings for Securities Class Action

Updated Category News Views 201

Legal Investigation of Xerox Holdings Corporation Faruqi & Faruqi, LLP, a highly regarded national securities law firm, is currently investigating potential claims involving Xerox Holdings Corporation (NASDAQ: XRX). Investors who have suffered significant financial losses are encouraged to reach out to discuss options available to them. Investor Losses and Legal Options...

Continue Reading
Understanding the Risks of Sharing Back-to-School Photos

Updated Category News Views 240

Understanding the Risks of Sharing Back-to-School Photos As families across the nation prepare for a new school year, there’s an important reminder from experienced investigator and child advocate, Moses Castillo. Before sharing those back-to-school photos on social media, it's crucial to consider the potential dangers associated with such posts. The Hidden Dangers of...

Continue Reading
Intel's Journey: Overcoming Two Decades of Market Struggles

Updated Category News Views 111

Intel's Long Road to Recovery Intel has faced significant challenges over the past two decades. Its stock performance has been lackluster, rising only 2% compared to the NASDAQ 100, which has surged over 1,200%. This stark contrast raises questions about Intel's strategic decisions and future direction. Intel's leadership has stumbled in crucial areas that have allowed...

Continue Reading